A novel cofactor for p300 that regulates the p53 response

Molecular Cell

Volumn 4, Issue 3, 1999, Pages 365-376

  Shikama, Noriko ^a   Lee, Chang Woo ^a   France, Stephen ^a   Delavaine, Laurent ^a   Lyon, Jonathan ^a   Krstic Demonacos, Marija ^a   La Thangue, Nicholas B ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

POLYPEPTIDE; PROTEIN P53; REGULATOR PROTEIN; TRANSCRIPTION FACTOR;

APOPTOSIS; ARTICLE; GENETIC TRANSCRIPTION; MAMMAL CELL; NONHUMAN; PROTEIN ANALYSIS; TUMOR CELL LINE; YEAST;

MAMMALIA;

EID: 0033197703     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1097-2765(00)80338-X     Document Type: Article

References (50)

1. Arany, Z., Newsome, D., Oldread, E., Livingston, D.M., and Eckner, R. (1995). A family of transcriptional adaptor proteins targeted by the E1A oncoprotein. Nature 374, 81-84.
2. Attardi, L.D., Lowe, S.W., Brugarolos, J., and Jacks, T. (1996) Transcriptional activation by p53, but not induction of the p21 gene, is essential for oncogene-mediated apoptosis. EMBO J. 15, 3693-3701.
3. Avantaggiati, M.L., Ogryzko, V., Gardner, K., Giordano, A., Levine, A.S., and Kelly, K. (1997). Recruitment of p300/CBP in p53-dependent signal pathways. Cell 89, 1175-1184.
4. Bannister, A.J., and Kouzarides, T. (1996). The CBP co-activator is a histone acetyltransferase. Nature 384, 641-643.
5. Buck, V., Allen, K.E., Sørensen, T.S., Bybee, A., Hijmans, E.M., Voorhoeve, P.M., Bernards, R., and La Thangue, N.B. (1995). Molecular and functional characterisation of E2F-5, a new member of the E2F family. Oncogene 11, 31-38.
6. Caelles, C., Helmberg, A., and Karin, M. (1994). p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes. Nature 370, 220-223.
7. Chang, M., and Jaehning, J. (1997). A multiplicity of mediators: Alternative forms of transcription complexes communicate with transcription regulators. Nucleic Acid Res. 25, 4861-4865.
8. Chen, X., Ko, L.J., Jayaraman, L., and Prives, C. (1996). p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumour cells. Genes Dev. 10, 2438-2451.
9. Chen, H., Lin, R.J., Schiltz, R.L., Chakravarti, D., Nash, A., Nagy, L., Privalsky, M.L., Nakatani, Y., and Evans, R.M. (1997). Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300. Cell 90, 569-580.
10. Cho, Y., Gorina, S., Jeffrey, P.D., and Pavletich, N.P. (1994) Crystal structure of a p53 tumour suppressor-DNA complex: Understanding tumorigenic mutations. Science 265, 346-355.
11. de la Luna, S., Allen, K.E., Mason, S.L., and La Thangue, N.B. (1999). Integration of a growth-suppressing BTB/POZ domain protein with the DP component of the E2F transcription factor. EMBO J. 18, 212-228.
12. Eckner, R., McEwan, M.E., Newsome, D., Gerdes, M., Decaprio, J.A., Lawrence, J.B., and Livingston, D.M. (1994). Molecular cloning and functional analysis of the E1A-associated 300kD protein (p300) reveals a protein with properties of a transcriptional adaptor. Genes Dev. 8, 869-884.
13. Eckner, R., Yao, T.-S., Oldread, E., and Livingston, D.M. (1996) Interaction and functional collaboration of p300/CBPand bHLH proteins in muscle and B-cell differentiation. Genes Dev. 10, 2478-2490.
14. El-Deiry, W.S., Tokino, T., Velculescu, V.E., Levy, D.B., Parsons, R., Trent, J.M., Lin, D., Mercer, W.E., Kinzler, K.W., and Vogelstein, B. (1993). WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817-825.
15. Fields, S., and Jang, S.K. (1990). Presence of a potent transcription activating sequence in the p53 protein. Science 249, 1046-1049.
16. Friedlander, P., Haupt, Y., and Oren, M. (1996). A mutant p53 that discriminates between p53-responsive genes cannot induce apoptosis. Mol. Cell. Biol. 16, 4961-4971.
17. Girling, R., Partridge, J.F., Bandara, L.R., Burden, N., Totty, N.F., Hsuan, J.J., and La Thangue, N.B. (1993). A new component of the transcription factor DRTF1/E2F. Nature 362, 83-87.
18. Gu, W., and Roeder, R.G. (1997). Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90, 595-606.
19. Gu, W., Shi, X.-L., and Roeder, R.G. (1997). Synergistic activation of transcription by CBP and p53. Nature 387, 819-822.
20. Haupt, Y., Rowan, S., Shaulian, E., Vousden, K.H., and Oren, M. (1995). Induction of apoptosis in HeLa cells by trans-activation-deficient p53. Genes Dev. 9, 2170-2183.
21. Haupt, Y., Maya, R., Kazaz, A., and Oren, M. (1997). Mdm2 promotes the rapid degradation of p53. Nature 387, 296-299.
22. Heng, H.H., and Tsui, L.-C. (1993). Modes of DAPI banding and simultaneous in situ hybridization. Chromosoma 102, 325-332.
23. Heng, H.H., Squire, J., and Tsui, L.-C. (1992). High-resolution mapping of mammalian genes by in situ hybridization to free chromatin. Proc. Natl. Acad. Sci. USA 89, 9505-9513.
24. Kamei, Y., Xu, L., Heinzel, T., Torchia, J., Kurokawa, R., Gloss, B., Lin, S.-C., Heyman, R.A., Rose, D.W., Glass, C.K., and Rosenfeld, M.G. (1996). A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85, 403-414.
25. Ko, L.-J., and Prives, C. (1996). p53: Puzzle and paradigm. Genes Dev. 10, 1054-1072.
26. Kubbutat, M.H.G., Jones, S.N., and Vousden, K.H. (1997). Regulation of p53 stability by Mdm2. Nature 387, 299-303.
27. Lee, C.-W., and La Thangue, N.B. (1999). Promoter specificity and stability control of the p53-related protein p73. Oncogene 18, 4171-4181.
28. Lee, C.-W., Sørensen, T.S., Shikama, N., and La Thangue, N.B. (1998). Functional interplay between p53 and E2F through co-activator p300. Oncogene 16, 2695-2710.
29. Li, H., Gomes, P.J., and Chen, J.D. (1997). RAC3, a steroid/nuclear receptor-associated co-activator that is related to SRC-1 and TIF2. Proc. Natl. Acad. Sci. USA 94, 8479-8484.
30. Lill, N.L., Grossman, S.R., Ginsberg, D., DeCaprio, J., and Livingston, D.M. (1997). Binding and modulation of p53 by p300/CBP co-activators. Nature 387, 823-827.
31. Lin, J., Chen, J., Elenbaas, B., and Levine, A.J. (1994). Several hydrophobic amino acids in the p53 amino-terminal domains are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein. Genes Dev. 8, 1235-1246.
32. Lundblad, J.R., Kwok, R.P.S., Laurance, M.E., Harter, M.L., and Goodman, R.H. (1995). Adenoviral E1A-associated protein p300 as a functional homologue of the transcriptional co-activator CBP. NaTure 374, 85-88.
33. Miura, I., Graziano, S.L., Cheng, J.Q., Doyle, L.A., and Testa, J.R. (1992). Chromosome alterations in human small cell lung cancer: frequent involvement of 5q. Cancer Res. 52, 1322-1328.
34. Miyashita, T., and Reed, J.C. (1995). Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80, 293-299.
35. Ogryzko, V.V., Schitz, R.L., Russanova, V., Howard, B.H., and Nakatani, Y. (1996). The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87, 953-959.
36. Oliner, J.D., Pietenpol, J.A., Thiagalingam, S., Gyuris, J., Kinzler, K.W., and Vogelstein, B. (1993). Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53. Nature 362, 857-860.
37. Roth, J., Dobbelstein, M., Freedman, D.A., Shenk, T., and Levine, A.J. (1998). Nucleo-cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein. EMBO J. 17, 554-564.
38. Sabbatini, P., Lin, J., Levine, A.J., and White, E. (1995). Essential role for p53-mediated transcription in E1A-induced apoptosis. Genes Dev. 9, 2184-2192.
39. Sakaguchi, K., Herrera, J.E., Saito, S., Miki, T., Bustin, M., Vassilev, A., Anderson, C.W., and Appella, E. (1998). DNA damage activates p53 through a phosphorylation-acetylation cascade. Genes Dev. 12, 2831-2841.
40. Shikama, N., Lyon, J., and La Thangue, N.B. (1997). The p300/CBP family: Integrating signals with transcription factors and chromatin. Trends Cell Biol. 7, 230-236.
41. Sørensen, T.S., Girling, R., Lee, C.-W., Gannon, J., Bandara, L.R. and La Thangue, N.B. (1996). Functional interaction between DP-1 and p53. Mol. Cell. Biol. 16, 5888-5895.
42. Tavassoli, M., Steingrimsdottir, H., Pierce, E., Jiang, X., Alagoz, M., Faraneh, F., and Campbell, I.G. (1996). Loss of heterozygosity on chromosome 5q in ovarian cancer is frequently accompanied by TP53 mutation and identifies a tumour suppressor gene locus at 5q13.1-21. Br. J. Cancer 74, 115.
43. Thomas, A., and White, E. (1998). Suppression of the p300-dependent mdm2 negative-feedback loop induces the p53 apoptotic function. Genes Dev. 12, 1975-1985.
44. Torchia, J., Rose, D.W., Inostroza, J., Kamei, Y., Westin, S., Glass, C.K., and Rosenfeld, M.G. (1997). The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function. Nature 387, 677-684.
45. Vojtek, A.B., Hollenberg, S.M., and Cooper, J.A. (1993). Mammalian ras interacts directly with the serine/threonine kinase raf. Cell 74, 205-214.
46. Weiland, I., and Bohm, M. (1994). Frequent allelic deletion at a novel locus on chromosome 5 in human lung cancer. Cancer Res. 54, 1772-1774.
47. White, E. (1996). Life, death, and the pursuit of apoptosis. Genes Dev. 10, 1-15.
48. Wu, X., Merup, M., Juliusson, G., Jansson, M., Stellan, B., Grander, D., Zabarovsky, E., Liu, Y., Spasokoukotskaja, T., Gahrton, G., and Einhorn, S. (1997). Characterization of a hairy cell leukaemia-associated 5q13.3 inversion breakpoint. Genes Chrom. Cancer 20, 337-346.
49. Yang, X.-J., Ogryzko, V.V., Nishikawa, J.-I., Howard, B.H., and Nakatani, Y. (1996). A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A. Nature 382, 319-324.
50. Zamanian, M., and La Thangue, N.B. (1992). Adenovirus E1a prevents the retinoblastoma gene product from repressing the activity of a cellular transcription factor. EMBO J. 11, 2603-2610.